|
⚲
|
| Keyboard |
| Humer Kristian
✚
|
|
|---|---|
| CIK # | 0001872280 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001872280] | |
| 4 | [0001872280] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| 4D Molecular Therapeutics Inc | |
| Humer Kristian | |
| Foghorn Therapeutics Inc | |
| Faeth Therapeutics Inc | |
| Miragen Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
4D Molecular Therapeutics Inc FDMT
Stock Option (Right to Buy) · derivative
|
2025-12-09 | Grant | 480,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2025-05-21 | Grant | 19,000 | $0.00 | |
|
Foghorn Therapeutics Inc FHTX
Stock Option (right to buy) · derivative
|
2025-01-22 | Grant | 120,000 | $4.37 | 524,400 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 19,000 | $0.00 | |
|
Foghorn Therapeutics Inc FHTX
Stock Option (Right to buy) · derivative
|
2024-04-16 | Grant | 275,000 | $6.03 | 1,658,250 |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-07-10 | Grant | 4,466 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2023-07-10 | Grant | 14,550 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-02-08 | Grant | 108,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2022-06-10 | Grant | 14,550 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2022-06-10 | Grant | 4,466 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2022-02-02 | Grant | 90,000 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2021-12-31 | Grant | 121,371 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2021-07-30 | Grant | 16,667 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2021-07-26 | Grant | 360,000 | $0.00 |